Return
Vasoactive intestinal peptide attenuates form-deprivation myopia in guinea pigs by suppressing the Wnt/β-catenin pathway along the retina-choroid-scleral axis
Y
X
Y
Q
W
H
Z
X
DOI:10.1016/j.exer.2026.111037.png)
Abstract
En 中文
• Dose-dependent myopia inhibition by VIP is mediated via the scleral Wnt/β-catenin pathway. • VIP down-regulates the aberrantly activated scleral Wnt/β-catenin pathway. • VIP restores the irregular collagen arrangement in myopic sclera. • This study identifies a novel target (VIP) for potential myopia control therapy.
Keywords:
VIP
myopia
Wnt/β-catenin pathway
sclera
collagen arrangement
Journal
IF:
2.7
Papers:
7.6K
Citations:
1.6W
